-
Date Time 10:00 - 11:00
Location Webinar Timezone ET - America/New York
Overview:
70% of clinical research sites report an increase in study execution burden, but when investigators have a superior experience with a sponsor they may enroll twice as many patients1.
This webinar will present evidence-based strategies to become partner of choice for high-performing sites by easing the site burden2 while making clinical trials more efficient. This includes optimising site feasibility and activation, improving staff training and study compliance, and early engagement with sites to improve their understanding of the study protocol. Global case studies will be shared, showing how these strategies allow for wider access to clinical trials and accelerated study start-up and enrolment.
1 Tufts Report, Volume 25, Number 1, Jan/Feb 2023
2 The Clinical Trial Challenge: To Win Patients, Win Over Physicians | Bain & Company
Audience:
Professionals in the following areas in the pharmaceutical, biotech, spaces: Clinical Development, Project Management, Clinical Operations, Procurement, Outsourcing, Strategy and Innovation, Protocol Development, Patient-Centric Innovation, Data Management, Decentralised Clinical Trial Operations, Clinical Science, Outcomes research, Clinical trial planning and optimization, Patient-centricity, site feasibility, site identification, site intelligence
Speakers:
Ana Fernandez-Ramos, PhD
Ana is the Lead Clinical Trial Liaison (CTL) for Europe, currently leading CTL activities for multiple projects at ICON, with over 7 years CRO experience. PhD trained with academic, industry and international site experience, Ana is highly skilled in providing clinical trial strategy for sponsors and cultivating site relationships, impacting trial efficiency and improving patient recruitment. She’s experienced in national and international scientific conferences and workshops, delivering audience-specific scientific presentations to both scientific and non-scientific audiences. Ana’s background is in novel pharmacological targets for solid transplants, but she has clinical expertise in vaccine trials, hematology, immunology (CD, UC, Lupus), chronic kidney disease, neurology (Alzheimer’s disease), solid cancers, and others.
Mary Pevear
Mary is currently working at Kura Oncology, Inc. as the Director of Clinical Trial Management. Prior to this, they worked at EMD Serono, Inc. as a Senior Clinical Trial Lead and Clinical Trial Lead. Before that, Mary held the position of Research Project Manager at Boston Medical Center (BMC) where they supervised medical students and residents involved in orthopedic research. Mary also worked as a Clinical Research Supervisor at Tufts Medical Center, where they facilitated research procedures and managed a comprehensive internal registry. Their early experience includes working as a Recruitment Coordinator at Tufts University, where they led subject recruitment and managed student interns.
Mary Pevear's education history begins in 2008 when they attended John Cabot University for a brief period. During their time there, they pursued studies in English and Political Science. In 2006, they enrolled in Emmanuel College (Boston) and stayed until 2010, earning a Bachelor of Arts degree in English Communications and Political Science. Later, in 2014, they attended Tufts University School of Medicine, where they obtained a Master of Public Health (MPH) degree, focusing on Health Communication.
Manuel Rodriguez, MD
Dr. Rodriguez serves as the Primary Investigator at the Florida Research Institute (FRI), where he leads a dedicated team in coordinating innovative clinical studies. With a commitment to advancing overall health, Dr. Rodriguez plays a pivotal role in highlighting FRI’s efforts to improve health outcomes through rigorous clinical trial research, having completed over 30 trials including fatty liver disease, cirrhosis, IBS, IBD, weight management, cancer screening, NSAID induced GI diseases, and device trials among others. His leadership and expertise contribute significantly to the institute’s mission of enhancing health and medical knowledge.
Dr. Rodriguez is board certified in Internal Medicine and Gastroenterology. He completed his residency and internship at University of Miami, Jackson Memorial Hospital and his fellowship at University of Texas, MD Anderson Cancer Center. Dr Rodriguez holds many professional memberships, including the American Society for Gastrointestinal Endoscopy, American Gastroenterology Association, American College of Gastroenterology.